These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35505495)

  • 1. Platelet transfusion and anticoagulation in hematological cancer-associated thrombosis and thrombocytopenia: The CAVEaT multicenter prospective cohort.
    Booth S; ; Desborough M; Curry N; Stanworth S
    J Thromb Haemost; 2022 Aug; 20(8):1830-1838. PubMed ID: 35505495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes.
    Samuelson Bannow BT; Walter RB; Gernsheimer TB; Garcia DA
    J Thromb Thrombolysis; 2017 Nov; 44(4):442-447. PubMed ID: 28884390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation management and related outcomes in patients with cancer-associated thrombosis and thrombocytopenia: A systematic review and meta-analysis.
    Wang TF; Carrier M; Carney BJ; Kimpton M; Delluc A
    Thromb Res; 2023 Jul; 227():8-16. PubMed ID: 37196605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center.
    Labrador J; González-Rivero J; Monroy R; Lozano FS; López-Corral L; Caballero MD; Bastida JM; González-Porras JR
    Thromb Res; 2016 Jun; 142():52-6. PubMed ID: 26922092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home parenteral nutrition-associated thromboembolic and bleeding events: results of a cohort study of 236 individuals.
    Barco S; Heuschen CB; Salman B; Brekelmans MP; Serlie MJ; Middeldorp S; Coppens M
    J Thromb Haemost; 2016 Jul; 14(7):1364-73. PubMed ID: 27122107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis.
    Hsu C; Patell R; Zwicker JI
    Blood Adv; 2023 Sep; 7(17):4721-4727. PubMed ID: 36170802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia.
    Khanal N; Bociek RG; Chen B; Vose JM; Armitage JO; Bierman PJ; Maness LJ; Lunning MA; Gundabolu K; Bhatt VR
    Am J Hematol; 2016 Nov; 91(11):E468-E472. PubMed ID: 27489982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
    Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
    J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of distal deep vein thrombosis.
    Kirkilesis G; Kakkos SK; Bicknell C; Salim S; Kakavia K
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013422. PubMed ID: 32271939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial.
    Barginear MF; Gralla RJ; Bradley TP; Ali SS; Shapira I; Greben C; Nier-Shoulson N; Akerman M; Lesser M; Budman DR
    Support Care Cancer; 2012 Nov; 20(11):2865-72. PubMed ID: 22421738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study.
    Carney BJ; Wang TF; Ren S; George G; Al Homssi A; Gaddh M; Connolly GC; Shah VI; Bogue T; Bartosic A; Neuberg D; Baumann Kreuziger L; Zwicker JI;
    Blood Adv; 2021 Dec; 5(24):5546-5553. PubMed ID: 34662892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes Associated With Inferior Vena Cava Filters Among Patients With Thromboembolic Recurrence During Anticoagulant Therapy.
    Mellado M; Pijoan JI; Jiménez D; Muriel A; Aujesky D; Bertoletti L; Decousus H; Barrios D; Clará A; Yusen RD; Monreal M;
    JACC Cardiovasc Interv; 2016 Dec; 9(23):2440-2448. PubMed ID: 27838262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.
    Houghton DE; Key NS; Zakai NA; Laux JP; Shea TC; Moll S
    Leuk Lymphoma; 2017 Nov; 58(11):2573-2581. PubMed ID: 28393576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet agents for the treatment of deep venous thrombosis.
    Flumignan CD; Nakano LC; Baptista-Silva JC; Flumignan RL
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012369. PubMed ID: 35876829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
    Farge D; Debourdeau P; Beckers M; Baglin C; Bauersachs RM; Brenner B; Brilhante D; Falanga A; Gerotzafias GT; Haim N; Kakkar AK; Khorana AA; Lecumberri R; Mandala M; Marty M; Monreal M; Mousa SA; Noble S; Pabinger I; Prandoni P; Prins MH; Qari MH; Streiff MB; Syrigos K; Bounameaux H; Büller HR
    J Thromb Haemost; 2013 Jan; 11(1):56-70. PubMed ID: 23217107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry.
    Barillari G; Londero AP; Brenner B; Nauffal D; Muñoz-Torrero JF; Del Molino F; Moustafa F; Madridano O; Martín-Martos F; Monreal M;
    Eur J Intern Med; 2016 Jul; 32():53-9. PubMed ID: 26972931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation for perioperative thromboprophylaxis in people with cancer.
    Matar CF; Kahale LA; Hakoum MB; Tsolakian IG; Etxeandia-Ikobaltzeta I; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009447. PubMed ID: 29993117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after Vena Cava Filter Use in Patients with Cancer-Associated Venous Thromboembolism and Contraindications to Anticoagulation.
    Quezada A; Jiménez D; Bikdeli B; Muriel A; Aramberri M; López-Jiménez L; Sahuquillo JC; Otero R; Porfidia A; Monreal M;
    Thromb Haemost; 2020 Jul; 120(7):1035-1044. PubMed ID: 32422681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vena caval filters for the prevention of pulmonary embolism.
    Young T; Sriram KB
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD006212. PubMed ID: 33027844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.